PetMed Express Inc PETS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PETS is a good fit for your portfolio.
News
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
-
Both Pets and Pet Parents Feel the Strain of Separation Anxiety When Apart, According to a New Survey from PetMeds®
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of PetMed Express, Inc. - PETS
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
-
PetMeds® Announces the Formation of Veterinarian Advisory Board
-
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of PetMed Express, Inc. (PETS) on Behalf of Investors
-
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of PetMed Express, Inc. (PETS) on Behalf of Investors
-
The Law Offices of Frank R. Cruz Announces Investigation of PetMed Express, Inc. (PETS) on Behalf of Investors
Trading Information
- Previous Close Price
- $7.30
- Day Range
- $7.13–7.45
- 52-Week Range
- $5.50–22.01
- Bid/Ask
- $7.11 / $7.15
- Market Cap
- $150.78 Mil
- Volume/Avg
- 122,611 / 493,626
Key Statistics
- Price/Earnings (Normalized)
- 84.89
- Price/Sales
- 0.55
- Dividend Yield
- 16.42%
- Dividend Yield (Forward)
- —
- Total Yield
- 16.42%
Company Profile
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Stock Style Box
- Small Value
- Total Number of Employees
- 302
- Website
- https://www.petmeds.com
Valuation
|
Metric
|
PETS
|
|---|---|
Price/Earnings (Normalized) | 84.89 |
Price/Book Value | 1.36 |
Price/Sales | 0.55 |
Price/Cash Flow | 29.38 |
Price/Earnings
PETS
Financial Strength
|
Metric
|
PETS
|
|---|---|
Quick Ratio | 1.37 |
Current Ratio | 2.10 |
Interest Coverage | — |
Quick Ratio
PETS
Profitability
|
Metric
|
PETS
|
|---|---|
Return on Assets (Normalized) | 0.35% |
Return on Equity (Normalized) | 0.47% |
Return on Invested Capital (Normalized) | −1.59% |
Return on Assets
PETS
Pharmaceutical Retailers Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
WBA
| Walgreens Boots Alliance Inc | Sfrx | $17.3 Bil | |
RADLY
| Raia Drogasil SA ADR | Dyxds | $10.3 Bil | |
ALBBY
| Alibaba Health Information Technology Ltd ADR | Mxnmjc | $8.1 Bil | |
ALBHF
| Alibaba Health Information Technology Ltd | Gvdzfbw | $8.1 Bil | |
CLCGY
| Clicks Group Ltd ADR | Wqwsjs | $3.8 Bil | |
WLCGF
| Welcia Holdings Co Ltd | Vrfdx | $3.7 Bil | |
SAEYY
| Redcare Pharmacy NV ADR | Gdr | $2.6 Bil | |
ZRSEF
| DocMorris AG | Mbv | $735.5 Mil | |
NBLYF
| Neighbourly Pharmacy Inc | Msmvv | $569.2 Mil | |
YI
| 111 Inc 1 ADR represents 2 Class Common stocks | Wjt | $179.7 Mil |